Will Bulging Eyes From Thyroid Eye Disease Go Away?
At a Glance
Bulging eyes from thyroid eye disease often do not fully return to normal after inflammation stops because enlarged eye muscles, extra fat, or scar-like tissue can remain. Mild cases may improve, while stable persistent bulging can sometimes be treated with orbital decompression.
In most cases, bulging eyes (medically known as proptosis or exophthalmos) caused by thyroid eye disease (TED) will not completely go back to normal on their own once the active inflammation stops [1]. While the redness, pain, and swelling will eventually settle when the disease becomes inactive, the physical expansion of tissues behind the eye often leaves some persistent bulging [2]. People with very mild cases might see spontaneous improvement, but a complete return to your pre-disease appearance rarely happens without treatment if your condition was moderate or severe [3][4].
Understanding Your Timeline: Rundle’s Curve
To understand why the eyes may remain bulging, it helps to look at a concept doctors call Rundle’s Curve. This is a classic medical model that describes the natural life cycle of thyroid eye disease [5]. It suggests the disease occurs in two main phases:
- The Active (Dynamic) Phase: The disease begins with a period of active inflammation. The immune system attacks the tissues around the eyes, causing them to become red, swollen, and painful [6]. During this time, symptoms often worsen before hitting a plateau [5]. While this active phase typically lasts anywhere from 1 to 3 years (often stabilizing around 18 to 24 months), this is only a general average [3][5]. The exact timeline varies from person to person.
- The Inactive (Static) Phase: Eventually, the disease enters a stable, inactive period [5]. The active inflammation stops, and symptoms like pain and redness fade away [1]. However, the eyes will usually stay in their new, bulging position [1].
Important: You cannot rely on a calendar alone to know if your disease is inactive. Eye specialists use specific clinical exams (like a Clinical Activity Score) and take regular measurements to determine when the disease has officially stopped changing [1].
Why Does the Bulging Stay?
During the active phase, inflammation causes the fat and muscles behind your eye to swell and expand [1]. As the disease transitions into the inactive phase, this expanded tissue does not simply shrink back down to its original size [2].
Instead, the body undergoes a tissue remodeling process. The tissues behind the eye accumulate extra orbital fat, the eye muscles remain enlarged, and rigid scar tissue (fibrosis) can form [7][1]. Because the space inside your bony eye socket is limited, this extra volume physically pushes the eyeball forward [7]. Even after the immune attack stops, this structural roadblock remains [2]. Additionally, retracted (pulled back) eyelids can persist, exposing more of the white of the eye and making the bulging look more pronounced [8].
Urgent Warning Signs
Do not wait for your disease to “burn out” if you experience any of the following symptoms. Seek prompt or emergency eye care immediately, as these can be signs of sight-threatening disease or optic nerve compression [9]:
- New or worsening vision loss or blurriness
- Colors looking “washed out” or less vibrant
- Missing patches in your field of vision
- Severe eye pain
- Inability to close your eyelids completely
Managing Symptoms While You Wait
While waiting for the disease to stabilize, you can protect your eyes and manage discomfort. Your doctor may recommend preservative-free artificial tears or nighttime ointments to prevent dryness, and wearing sunglasses can help with light sensitivity [6].
Note: Quitting smoking and avoiding secondhand smoke is one of the most effective steps you can take. Smoking is strongly associated with worse TED, greater proptosis, and poorer responses to treatment [10].
Moving Forward: Rehabilitative Surgery
Just because the bulging may persist does not mean you have to live with it if it bothers you. Once an ophthalmologist confirms your eye disease has been completely stable and inactive—often requiring a period of at least 6 months with controlled thyroid hormone levels—you can discuss rehabilitative surgery [11][12].
Orbital decompression surgery is an established rehabilitative option to reduce persistent bulging [7]. In this procedure, a specialized surgeon removes small amounts of bone and/or fat from behind the eye, creating more room for the eye to settle backward [13][14].
It is important to understand that surgery is intended to improve your appearance and function, but it may not perfectly restore your eyes to how they looked before TED. Decompression also carries risks, including causing or worsening double vision, altering facial symmetry, or causing temporary numbness [15].
If multiple procedures are needed, specialists often address them in a staged order [9]:
- Orbital decompression to improve the bulging.
- Strabismus (eye muscle) surgery to correct any remaining double vision.
- Eyelid surgery to improve retracted eyelids and symmetry.
Common questions in this guide
Will my eyes return to their old appearance when thyroid eye disease settles?
What causes the eyes to stay prominent after the inflammation stops?
How long does the active phase of thyroid eye disease usually last?
Which symptoms of thyroid eye disease need urgent eye care?
Could surgery reduce bulging eyes after thyroid eye disease?
Will orbital decompression make my eyes look exactly as they did before thyroid eye disease?
Can quitting smoking help if I have thyroid eye disease?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on thyrotoxic exophthalmos.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Has my thyroid eye disease officially entered the inactive, stable phase according to clinical exams?
- 2.How much of my bulging is caused by active swelling versus permanent tissue changes like extra fat or fibrosis?
- 3.What are the risks of orbital decompression for my specific anatomy, especially regarding double vision?
- 4.If I choose to have decompression surgery, will it change my need for other treatments like eyelid or eye muscle surgery?
References
References (15)
- 1
Teprotumumab for the treatment of thyroid eye disease.
Fallahi P, Ragusa F, Paparo SR, et al.
Expert opinion on biological therapy 2023; (23(2)):123-131 doi:10.1080/14712598.2023.2172328.
PMID: 36695097 - 2
Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm.
Wang Y, Patel A, Douglas RS
Therapeutics and clinical risk management 2019; (15()):1305-1318 doi:10.2147/TCRM.S193018.
PMID: 31814726 - 3
Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.
Bartalena L, Gallo D, Tanda ML, Kahaly GJ
Ophthalmic plastic and reconstructive surgery 2023; (39(6S)):S2-S8 doi:10.1097/IOP.0000000000002467.
PMID: 38054980 - 4
Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?
Anagnostis P, Boboridis K, Adamidou F, Kita M
Journal of endocrinological investigation 2017; (40(3)):257-261 doi:10.1007/s40618-016-0555-0.
PMID: 27664101 - 5
Rundle's Curve: A Useful Construct That Does Not Fit All.
Cruz AAV, Guimarães JA, Garcia DM
Ophthalmic plastic and reconstructive surgery 2023; (39(6S)):S40-S45 doi:10.1097/IOP.0000000000002402.
PMID: 38054984 - 6
Thyroid eye disease.
Ferrari SM, Ragusa F, Elia G, et al.
Autoimmunity reviews 2026; (25(11)):104155 doi:10.1016/j.autrev.2026.104155.
PMID: 42537765 - 7
Thyroid-associated Ophthalmopathy.
Şahlı E, Gündüz K
Turkish journal of ophthalmology 2017; (47(2)):94-105 doi:10.4274/tjo.80688.
PMID: 28405484 - 8
Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method.
Young SM, Kim YD, Lang SS, Woo KI
Ophthalmic plastic and reconstructive surgery 2018; (34(6)):587-593 doi:10.1097/IOP.0000000000001120.
PMID: 29672347 - 9
Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review.
Ismailova DS, Belovalova IM, Grusha YO, Sviridenko NY
International medical case reports journal 2018; (11()):243-249 doi:10.2147/IMCRJ.S164372.
PMID: 30319289 - 10
Effect of smoking on retrobulbar blood flow in thyroid eye disease.
Sadeghi-Tari A, Jamshidian-Tehrani M, Nabavi A, et al.
Eye (London, England) 2016; (30(12)):1573-1578 doi:10.1038/eye.2016.184.
PMID: 27540833 - 11
[Multi-wall orbital decompression for disfiguring proptosis in patients with mild or moderate thyroid eye disease].
Wang Y, Yang N, Li YY, Xiao LH
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2017; (53(2)):128-135 doi:10.3760/cma.j.issn.0412-4081.2017.02.011.
PMID: 28260364 - 12
Technique for modified transantral orbital decompression for improved cosmesis in stable thyroid eye disease.
Lu JE, Bergman M, Burnstine MA
International journal of oral and maxillofacial surgery 2021; (50(11)):1440-1442 doi:10.1016/j.ijom.2021.02.006.
PMID: 33658150 - 13
Strategies in Surgical Decompression for Thyroid Eye Disease.
Cheng AMS, Wei YH, Liao SL
Oxidative medicine and cellular longevity 2020; (2020()):3537675 doi:10.1155/2020/3537675.
PMID: 32963693 - 14
Two walls versus three wall orbital decompression for thyroid eye disease: A systematic review and meta-analysis.
Iftikhar H, Deewani MH, Abbas SA, et al.
JPMA. The Journal of the Pakistan Medical Association 2025; (75(5)):777-781 doi:10.47391/JPMA.10271.
PMID: 40500824 - 15
Bony Orbital Surgery for Graves' Ophthalmopathy.
Ong AA, DeVictor S, Vincent AG, et al.
Facial plastic surgery : FPS 2021; (37(6)):692-697 doi:10.1055/s-0041-1735638.
PMID: 34500489
This page is for informational purposes only and does not constitute medical advice. An ophthalmologist should evaluate your eye stability, vision changes, and whether treatment for persistent bulging is appropriate.